A Wealth of Experience

We have collaborated with our clients on projects to research liver disease, liver treatment, and complications and comorbidities of liver disease. Our experience includes:

  • Acute Liver Failure
  • Hepatitis Infection
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
  • Hepatoxicity
  • Liver Steatosis
  • Thrombocytopenia in chronic hepatitis C

Types of Projects

We have implemented studies to help our clients develop strategies in the hepatic market and to develop and gain market access for products to treat liver disease and complications arising from treatment of liver disease.

Recent projects have included:

Our Experts

Isobel Pearson
Director, Health Economics, Health Technology Assessment
Keith Davis
Head, Health Economics
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Josephine Mauskopf
Vice President, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Caroline Ling
Senior Director and HTA Specialist Market Access and Outcomes Strategy
Annete Njue
Director, Market Access and Outcomes Strategy
Xiaolei Zhou
Director, Biostatistics

Selected Recent Hepatic Publications

Forns J, Pottegard A, Reinders T, Poblador-Plou B, Morros R, Brandt L, Cainzos-Achirica M, Hellfritzsch M, Schink T, Prados-Torres A, Giner-Soriano M, Hallas J, Cortes J, Hagg D, Jacquot E, Deltour N, Perez-Gutthann S, Pladevall M, Reutfors J. Antidepressant use in Denmark, Germany, Spain, and Sweden from 2009 to 2014: incidence and comorbidities of antidepressant initiators. Poster presented at the 35th Annual ICPE Conference; August 27, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):560.